This seemed to be where the momentum was heading, but its official today that Paul Kirk will be getting the interim appointment.
http://m.www.yahoo.com/_ylt=Aj…
From my perspective, this has some pluses and minuses. The obvious minus is that he was a pharmaceutical lobbyist which IMO won’t effect his voting record but its some minor bad PR. The pluses are that he’s got the backing of the Kennedy family which should kill any backlash because he’s picking an insider with minimal name id. The other benefit and this is the biggest one IMO is that he’s a Kennedy insider and most Kennedy staffers will be willing to stay on for him for the next 3.5 months which may not have been the case with Dukakis.